Tag Page Stocks

Why Abivax Stock Is Suddenly on Fire

Ever dream of a stock that skyrockets overnight? That’s what happened with Abivax, a French biotech company. Thanks to rumors that pharma giant Eli Lilly might buy them, Abivax shares shot up over 11% in a day—and a jaw-dropping 1,800% this year! The buzz? Abivax’s new ulcerative colitis drug is showing big promise. If you’re into biotech, this is one to watch—just remember, rumors can make stocks wild! #Business #Market #stocks

Beyond Nvidia: The AI Infrastructure Trio Billionaires Are Quietly Buying https://www.linkedin.com/pulse/beyond-nvidia-ai-infrastructure-trio-billionaires-quietly-grok3-7k2lc Disclaimer: This is not investment advice. Always conduct your own research. While Nvidia grabs headlines, the smartest money is rotating into the “picks and shovels” of AI infrastructure. A recent Millionaires Investment Secrets video spotlighted three names seeing explosive institutional accumulation: Vertiv (VRT), Arista Networks (ANET), and Nebius Group (NBIS). Quick, fact-checked breakdown from Q3 earnings and 13F filings: 1. Vertiv (VRT) – Liquid Cooling Leader
Q3 revenue $2.68B (+29% YoY), backlog $9.5B, book-to-bill 1.4x. FY25 guide lifted to +27% revenue and +44% EPS.
Leon Cooperman holds 2.1M shares; institutions own 90%.
+60% YTD, 34x fwd P/E. Target $210. 2. Arista Networks (ANET) – GPU Networking King
Q3 revenue $2.31B (+27.5% YoY), 21st straight beat. Q4 guide +19%, margins 62-63%.
Steve Cohen’s Point72 added 212K shares; Tiger Global loading up.
Trades 46x fwd earnings. Target $184 (40% upside by 2027). 3. Nebius Group (NBIS) – Pure-Play AI Cloud
Q3 revenue +355% YoY, 100% utilization, $22B+ in contracts (Meta + Microsoft).
+232% YTD despite 78x sales multiple. Target $164 (79% upside). Macro tailwind: Hyperscalers plan $300B+ capex in 2025; total AI infra TAM projected at $7T by 2030. Billionaires are voting with their wallets—Q3 13Fs show heavy net buying across all three. These are not cheap (avg ~45x fwd), and risks include capex pull-forwards, energy shortages, and execution delays. Still, for investors seeking diversified exposure beyond semiconductors, this trio offers compelling leverage to the AI buildout. My take: Trim Nvidia, add 5–8% combined weight here on weakness. What’s your favorite AI infrastructure play? Drop it below. #AI #Investing #DataCenters #Stocks #Tech

Exicure’s Stem Cell Win: Is This Stock a Steal?

Heads up for anyone who likes a good bargain: Exicure’s stock just jumped 40% after their new stem cell drug helped almost every patient hit their treatment goal—fast. The big deal? Patients could get their cells collected the same day, making life a lot easier for folks facing tough transplants. Traders are buzzing that the stock’s still cheap, even after the pop. If you like a comeback story, keep an eye on this one! #Business #Market #stocks

Cloud Giants Shake Up the Chip Game

If you’re tracking tech stocks, here’s a coffee break scoop: Microsoft might be swapping chip partners, giving Broadcom a boost while Marvell’s stock took a 10% nosedive. The drama? Marvell could lose big cloud contracts to rivals, making investors nervous about its future growth. Meanwhile, Broadcom is quietly locking in new deals, showing that sometimes, slow and steady wins the race in the chip world. Keep an eye on who’s powering your favorite cloud apps! #Business #EntrepreneurshipStartup #stocks

When Short Sellers Get Burned: Shkreli vs. Biotech

Ever bet against a company and watched it skyrocket? That’s what happened to Martin Shkreli, who shorted Capricor Therapeutics, only to see its stock rocket 440% after good news about its new treatment for muscular dystrophy. The drama? Shkreli trashed the company’s science, but the market didn’t care—proving that betting against medical breakthroughs can seriously backfire. If you’re playing the stock game, remember: sometimes the underdog wins big! #Business #Market #stocks

Did You Miss These Hot Stocks Last Week?

Heads up, coffee crew! Last week, stocks like AST SpaceMobile and Dollar General shot up as tech and retail names wowed Wall Street with strong results. The big story? AI, chips, and cloud companies are back in the spotlight, making investors rethink what’s in their portfolios. If you’re looking to freshen up your investments, keep an eye on these movers—sometimes, the best gains come from sectors everyone’s buzzing about! #Business #Market #stocks

Did You Catch These Stock Winners Last Week?

If you checked your investment app last week, you might've noticed some stocks popping off—Symbotic soared after beating sales expectations, and BitMine loaded up on Ethereum, riding the crypto wave. Precious metals stocks also got a boost after hints of a Fed rate cut. If you’re into tech, mining, or crypto, your portfolio might’ve just gotten a little shinier! #Business #Market #stocks

Stock Jumps After Name Change—Here’s Why

Ever notice how a company changing its name can make its stock pop? Entero Therapeutics just rebranded as GridAI Technologies, and their shares shot up 7%. The buzz? They recently bought Grid AI Corp, which is all about using AI to make power grids smarter. For regular folks, this means more reliable electricity in the future—and a reminder that sometimes, a new name (and a little AI) can spark big market moves! #Business #Industry #stocks

Drone Stocks Are Flying High—Here’s Why

Ever wonder why some stocks just take off? Ondas, a company making smart drone tech, just landed a huge airport deal in Europe and invested big in military robots. Their revenue shot up six times compared to last year, and their stock price soared over 27% in a day. The buzz? Drones aren’t just for fun anymore—they’re protecting airports and helping the military, which means investors are paying attention. If you’re looking for a hot sector, keep an eye on companies blending tech with real-world security. #Business #Market #stocks